Clinical Trial Update: Panobinostat/Velcade in Multiple Myeloma [Phase 1]

View source ↗

Summary

A phase 1 study evaluating panobinostat in combination with Velcade (bortezomib) for multiple myeloma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Panobinostat (Panobinostat)
• Velcade (bortezomib)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED